Fresenius company profile
Company profile
Fresenius has 179,493 employees and is headquartered in Bad Homburg vor der Höhe, Germany.
Hospitals, clinics, physicians and patients with chronic or critical illnesses in North America, Europe, Asia-Pacific, Latin America and Africa are the customers of Fresenius SE & Co. KGaA. Its Fresenius Kabi unit supplies biopharmaceuticals, clinical nutrition, biosimilars, generic injectable drugs, IV fluids, infusion pumps, apheresis machines and cell therapy devices. The Fresenius Helios unit runs hospitals, medical care centers, occupational health and outpatient centers and provides medical diagnostics. The company is also working with SAP SE and Avelios Medical GmbH on a cloud-native, modular hospital information system with AI integration.
In the fiscal year ended December 2025, revenue reached EUR 22.9 billion, up 4.2% from the previous year, and net income was EUR 1.3 billion. The group employs 179,493 people. Founded in 1912, it is headquartered in Bad Homburg vor der Höhe, Germany, and adopted its current name in January 2011.
Company facts
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- Germany
- Headquarters
- Else-Kröner-Straße 1, 61352, Bad Homburg vor der Höhe
- Employees
- 179,493
- Chief executive
- Michael Sen
- Founded
- 1912
- Fiscal year
- January - December
- Listing
- FRE · Xetra
- Indices
- DAX
- Currency
- EUR
- ISIN
- DE000FRE5EN2
- Website
- fresenius.com
Fresenius and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| FreseniusFRE | Germany | $29.53B | 179,493 | 9.8% | 17.2 |
| Fresenius Medical CareFME | Germany | $11.77B | 106,291 | 10.3% | 12.1 |
| MedicoverMCOV.B | Sweden | $3.88B | 49,000 | 7.4% | 38.5 |
| Spire Healthcare GroupSPI | United Kingdom | $1.31B | 17,800 | 6.2% | — |
| TerveystaloTTALO | Finland | $848.65M | 8,111 | 8.9% | 13.5 |
| Tenet HealthcareTHC | United States | $23.2B | 77,000 | 19.1% | 8.53 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
